Drug intelligence / Profile preview

ORB Ocular Emulsion

Development stage: Preclinical
Lead developer: ORB
Administration: Ophthalmic

Overview

ORB Ocular Emulsion is an investigational ophthalmic emulsion developed as an ocular surface lubricant intended for the treatment of dry eye disease. The formulation is described as a "preserved ocular emulsion," designed to be used as-needed for lubrication and symptomatic relief for patients experiencing dry eye symptoms. The detailed mechanism of action, specific active pharmaceutical ingredient(s), and excipient profile are not specified in the currently available literature. It is being studied in clinical trials for efficacy and safety in treating dry eye, but is not yet approved or marketed[9].

Brand names: ORB Ocular Emulsion
Other names: ORB Preserved Ocular Emulsion

Beyond the preview

Go deeper on ORB Ocular Emulsion.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ORB Ocular Emulsion.

Explore the full profile